| PRECLINICAL | evidence | Self-assembly of palmitoyl lipopeptides used in skin care products. | GHK | — | 2013-07-23 |
| PRECLINICAL | evidence | Stem cell recovering effect of copper-free GHK in skin. | GHK | preclinical | 2012-11-01 |
| PRECLINICAL | evidence | Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-alpha-dependent IL-6 secretion in normal human dermal fibroblasts. | GHK | preclinical | 2012-11-01 |
| PRECLINICAL | evidence | The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. | GHK-Cu | — | 2012-01-01 |
| PRECLINICAL | evidence | Next-generation personalized drug discovery: the tripeptide GHK hits center stage in chronic obstructive pulmonary disease. | GHK | — | 2012-01-01 |
| PRECLINICAL | evidence | Thermodynamic study of Cu2+ binding to the DAHK and GHK peptides by isothermal titration calorimetry (ITC) with the weaker competitor glycine. | GHK | — | 2012-01-01 |
| PRECLINICAL | evidence | A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. | GHK | — | 2012-01-01 |
| PRECLINICAL | evidence | The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. | GHK | Longevity & cellular aging | 2012-01-01 |
| PRECLINICAL | evidence | In vitro evaluation of compression-coated glycyl-L-histidyl-L-lysine-Cu(II) (GHK-Cu2+)-loaded microparticles for colonic drug delivery. | GHK-Cu | — | 2011-11-01 |
| PRECLINICAL | evidence | In vitro evaluation of compression-coated glycyl-L-histidyl-L-lysine-Cu(II) (GHK-Cu2+)-loaded microparticles for colonic drug delivery. | GHK | — | 2011-11-01 |
| PRECLINICAL | evidence | X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. | GHK | — | 2011-08-29 |
| PRECLINICAL | evidence | Human skin penetration of a copper tripeptide in vitro as a function of skin layer. | Copper tripeptide | Inflammation | 2011-01-01 |
| PRECLINICAL | evidence | Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy. | Copper tripeptide | Inflammation | 2010-11-01 |
| PRECLINICAL | evidence | Synthesis of orthogonally protected azahistidine: application to the synthesis of a GHK analogue. | GHK | — | 2010-01-01 |
| PRECLINICAL | evidence | Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics. | GHK | — | 2009-05-08 |
| PRECLINICAL | evidence | A 1 : 2 copper(II)-tripeptide complex for DNA binding and cleavage agent under physiological conditions. | Copper tripeptide | — | 2009-05-01 |
| PRECLINICAL | evidence | Copper-GHK increases integrin expression and p63 positivity by keratinocytes. | GHK | preclinical | 2009-04-01 |
| PRECLINICAL | evidence | Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. | GHK | — | 2008-07-15 |
| PRECLINICAL | evidence | The human tri-peptide GHK and tissue remodeling. | GHK-Cu | — | 2008-01-01 |
| PRECLINICAL | evidence | Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. | GHK-Cu | — | 2008-01-01 |
| PRECLINICAL | evidence | Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. | GHK | — | 2008-01-01 |
| PRECLINICAL | evidence | The human tri-peptide GHK and tissue remodeling. | GHK | Inflammation | 2008-01-01 |
| PRECLINICAL | evidence | Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. | GHK | — | 2007-11-06 |
| PRECLINICAL | evidence | Complexation of copper ions with histidine-containing tripeptides immobilized on solid surfaces. | Copper tripeptide | — | 2007-10-23 |
| PRECLINICAL | evidence | Glycyl-histidyl-lysine (GHK) is a quencher of alpha,beta-4-hydroxy-trans-2-nonenal: a comparison with carnosine. insights into the mechanism of reaction by electrospray ionization mass spectrometry, 1H NMR, and computational techniques. | GHK | — | 2007-09-01 |
| PRECLINICAL | evidence | Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state. | Gly-His-Lys-Cu | — | 2007-07-23 |
| PRECLINICAL | evidence | Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state. | GHK | — | 2007-07-23 |
| PRECLINICAL | evidence | New GHK hydrophobic derivatives: interaction with phospholipid bilayers. | GHK | — | 2007-06-15 |
| PRECLINICAL | evidence | In vitro observations on the influence of copper peptide aids for the LED photoirradiation of fibroblast collagen synthesis. | Cu-GHK | — | 2007-06-01 |
| PRECLINICAL | evidence | In vitro observations on the influence of copper peptide aids for the LED photoirradiation of fibroblast collagen synthesis. | GHK | — | 2007-06-01 |
| PRECLINICAL | evidence | ESI-MS study of the mechanism of glycyl-l-histidyl-l-lysine-Cu(II) complex transport through model membrane of stratum corneum. | GHK-Cu | — | 2007-04-30 |
| PRECLINICAL | evidence | ESI-MS study of the mechanism of glycyl-l-histidyl-l-lysine-Cu(II) complex transport through model membrane of stratum corneum. | GHK | — | 2007-04-30 |
| PRECLINICAL | evidence | NMR analysis of duplex d(CGCGATCGCG)2 modified by Lambda- and Delta-[Ru(bpy)2(m-GHK)]Cl2 and DNA photocleavage study. | GHK | — | 2007-03-01 |
| PRECLINICAL | evidence | A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices. | GHK | — | 2007-01-02 |
| PRECLINICAL | evidence | Synthesis, characterization, and DNA-binding studies of nitro(oligopyridine)ruthenium(II) complexes. | GHK | — | 2006-12-11 |
| PRECLINICAL | evidence | Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. | Copper tripeptide | preclinical | 2005-01-01 |
| PRECLINICAL | evidence | 1H NMR study of the enantioselective binding of lambda- and delta-[Ru(bpy)2(m-bpy-GHK)]Cl2 to the deoxynucleotide duplex d(5'-C1G2C3G4A5A6T7T8C9G10C11G12-3')2. | GHK | — | 2005-01-01 |
| PRECLINICAL | evidence | Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. | GHK | preclinical | 2005-01-01 |
| PRECLINICAL | evidence | Integrin alpha2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-alpha-driven colon cancer cells. | GHK | — | 2003-05-30 |
| PRECLINICAL | evidence | Synthesis and cytogenetic effects of aminoquinone derivatives with a di- and a tripeptide. | GHK | — | 2002-04-01 |
| PRECLINICAL | evidence | Interaction of several Ni(III) complexes of peptides with DNA; analysis by DNA-fiber EPR. | GHK | — | 2002-01-01 |
| PRECLINICAL | evidence | A new fluorescent chemosensor for copper ions based on tripeptide glycyl-histidyl-lysine (GHK). | GHK | — | 2001-10-18 |
| PRECLINICAL | evidence | Emerging issues of connexin channels: biophysics fills the gap. | GHK | — | 2001-08-01 |
| PRECLINICAL | evidence | Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity. | GHK | — | 2001-05-03 |
| PRECLINICAL | evidence | The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model. | Copper tripeptide-1 | Skin appearance & aging · preclinical | 2001-01-01 |
| PRECLINICAL | evidence | The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. | GHK-Cu | — | 2000-09-22 |
| PRECLINICAL | evidence | The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. | GHK | Skin appearance & aging | 2000-09-22 |
| PRECLINICAL | evidence | Immobilization of tripeptide growth factor glycyl-L-histidyl-L-lysine on poly(vinylalcohol)-quarternized stilbazole (PVA-SbQ) and its use as a ligand for hepatocyte attachment. | GHK | — | 1999-09-01 |
| PRECLINICAL | evidence | [Regulation of cell activity by the extracellular matrix: the concept of matrikines]. | GHK | — | 1999-01-01 |
| PRECLINICAL | evidence | Effectiveness of polyamidoamine dendrimers modified with tripeptide growth factor, glycyl-L-histidyl-L-lysine, for enhancement of function of hepatoma cells. | GHK | — | 1999-01-01 |